Form 8-K - Current report:
SEC Accession No. 0001564590-21-047258
Filing Date
2021-09-08
Accepted
2021-09-08 08:32:49
Documents
15
Period of Report
2021-09-08
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20210908.htm   iXBRL 8-K 44092
2 EX-10.1 xene-ex101_7.htm EX-10.1 147062
3 EX-99.1 xene-ex991_10.htm EX-99.1 14043
4 GRAPHIC gxurxzdrhbvy000001.jpg GRAPHIC 7563
  Complete submission text file 0001564590-21-047258.txt   384716

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xene-20210908.xsd EX-101.SCH 5701
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20210908_lab.xml EX-101.LAB 19292
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20210908_pre.xml EX-101.PRE 11485
8 EXTRACTED XBRL INSTANCE DOCUMENT xene-8k_20210908_htm.xml XML 3530
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 211240804
SIC: 2834 Pharmaceutical Preparations